Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis

B Marin, F Boumédiene, G Logroscino… - International journal …, 2017 - academic.oup.com
Background To assess the worldwide variation of amyotrophic lateral sclerosis (ALS)
incidence, we performed a systematic review and meta-analysis of population-based data …

Prognostic factors in ALS: a critical review

A Chio, G Logroscino, O Hardiman… - Amyotrophic lateral …, 2009 - Taylor & Francis
We have performed a systematic review to summarize current knowledge concerning factors
related to survival in ALS and to evaluate the implications of these data for clinical trials …

[PDF][PDF] The burden of disease and injury in Australia 2003

S Begg, T Vos, B Barker, C Stevenson, L Stanley… - 2007 - dro.deakin.edu.au
The burden of disease and injury in Australia 2003 Page 1 The burden of disease and injury in
Australia 2003 AUTHOR(S) S Begg, T Vos, B Barker, Christopher Stevenson, L Stanley, A …

Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues

G Logroscino, BJ Traynor, O Hardiman… - Journal of Neurology …, 2008 - jnnp.bmj.com
Amyotrophic lateral sclerosis (ALS) is a relatively rare disease with a reported population
incidence of between 1.5 and 2.5 per 100 000 per year. Over the past 10 years, the design …

Predictors of survival in patients with amyotrophic lateral sclerosis: a large meta-analysis

WM Su, YF Cheng, Z Jiang, QQ Duan, TM Yang… - …, 2021 - thelancet.com
Background The survival time of amyotrophic lateral sclerosis (ALS) is greatly variable and
protective or risk effects of the potential survival predictors are controversial. Thus, we aim to …

Machine learning in amyotrophic lateral sclerosis: achievements, pitfalls, and future directions

V Grollemund, PF Pradat, G Querin, F Delbot… - Frontiers in …, 2019 - frontiersin.org
Background: Amyotrophic Lateral Sclerosis (ALS) is a relentlessly progressive
neurodegenerative condition with limited therapeutic options at present. Survival from …

Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin

B Marin, G Logroscino, F Boumédiene… - European journal of …, 2016 - Springer
Background To review how the phenotype and outcome of amyotrophic lateral sclerosis
(ALS) change with variations in population ancestral origin (PAO). Knowledge of how PAO …

[HTML][HTML] The epidemiology of ALS and the role of population-based registries

E Beghi, G Logroscino, A Chiò, O Hardiman… - … et Biophysica Acta (BBA …, 2006 - Elsevier
Amyotrophic lateral sclerosis (ALS) is a degenerative disorder characterized by loss of
upper and lower motor neurons, culminating in respiratory insufficiency and death after 3–5 …

Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis/motor neurone disease in a clinical cohort

DJ Berlowitz, ME Howard, JF Fiore… - Journal of Neurology …, 2016 - jnnp.bmj.com
Background Respiratory failure is associated with significant morbidity and is the
predominant cause of death in motor neurone disease/amyotrophic lateral sclerosis …

Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study

S Zoccolella, E Beghi, G Palagano… - Journal of Neurology …, 2008 - jnnp.bmj.com
Objective: To measure survivorship and predictors of prognosis of amyotrophic lateral
sclerosis (ALS). Methods: Incident cases, diagnosed in the 1998–1999 period and classified …